Need to find a specific expert or member of a research group or division? Just search by role, division, name or browse our researchers A-Z.

Give a monthly donation to help us uncover how melanoma develops, grows and spreads — so we can develop new treatments to stop it in its tracks, and save more lives. Melanoma, the most dangerous type ...

The Institute of Cancer Research, London, strongly welcomes the decision by NICE to recommend the targeted breast cancer drug, capivasertib, in combination with fulvestrant, for treating the most ...

Scientists at The Institute of Cancer Research, London, have found a way to identify people with inflammatory bowel disease (IBD) who are at the highest risk of developing bowel cancer. IBD includes ...

Newly identified therapeutic target may lead to effective treatments for the most common and dangerous form of brain cancerScientists have shown for the first time that some of the most persistent ...

The overuse of CT scans could cause over 100,000 cases of cancer in the US – with almost 10,000 cases in children, researchers have warned.

A spit test, where a sample can be collected at home, is more accurate at identifying future risk of prostate cancer for some men than the current standard PSA blood test, a new study reports. Results ...

Scientists discover the ‘roadmap’ that aggressive cancer uses to spread around the body – identifying ways to block its escapeImage of human melanoma tissue, with melanoma cells in green and purple ...

ASCO 2025: AI test determines best prostate cancer treatment – which could save NHS moneyA new AI test can pick out which men with high-risk prostate cancer that has not spread will require ...

Thousands of patients with a common type of blood cancer could benefit from a new drug combination, while others could see their disease kept at bay for longer.

Innovative neuroblastoma research could lead to tailored treatments for high-risk patientsNew research has provided insight into the biological mechanisms that may contribute to poor outcomes in ...

Scientists from the ICR have developed a tool that can predict how bowel cancer adapts to treatment – helping researchers to design new personalised drugs that will keep patients living well for ...